Purchase Short-Term Access

Is It Safe to Conclude that Beers Criteria Medications Led to Few Adverse Events?
Daniel S. Budnitz, MD, MPH; Nadine Shehab, PharmD; Scott R. Kegler, PhD; Chesley L. Richards, MD, MPH
Annals of Internal Medicine 2008;148:629. doi:10.7326/0003-4819-148-8-200804150-00018

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.